Exendin-4, a GLP-1 receptor agonist regulates retinal capillary tone and restores microvascular patency after ischaemia-reperfusion injury.

Br J Pharmacol · 2020 · PMC7348095 · PMID 32232832

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Compared with the control group, PI3K expression was significantly reduced after I/R injury group and treatment with exendin‐4 showed a trend towards reversing that reduction.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.